Kalaris Therapeutics Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$6.00

+0.23 (+3.99%)

As of Apr 1, 2:51 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 83%

Hold 2 17%

Sell 0 0%

Price Target

Analyst Price Target +281.5% upside

Low Target $19.41

Average Target $22.89

High Target $38.59

Current Price $6.00

Current
$6.00

Target
$22.89

$19.41 $22.89 avg $38.59

Scenario Analysis

Bear Case

$19.41

223.5%

Low target

Base Case

$22.89

+281.5%

Avg target

Bull Case

$38.59

+543.2%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$11.88

-49.5% from high

52-Week Low

$2.14

+180.4% from low

Target vs 52W High

$22.89

+92.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%